✦ LIBER ✦

Implications & management of therapeutic apheresis in selected diseases

✍ Scribed by Peter Dau; Gayl Rogers

Publisher: John Wiley and Sons
Year: 1985
Tongue: English
Weight: 65 KB
Volume: 2
Category: Article
ISSN: 0733-2459
DOI: 10.1002/jca.2920020429

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Therapeutic apheresis in rheumatological

Therapeutic apheresis in rheumatological diseases

✍ Max Hamburger; Gayl Rogers 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 30 KB 👁 1 views

Dr. Hamburger was asked whether he would recommend the use of cytoxin or lymphacytapheresis first in the treatment of rheumatoid arthritis. He stated that he would recommend lymphacytapheresis first, especially in relatively young patients because of the multiple side effects and the risk of long-te

Therapeutic apheresis in autoimmune and

Therapeutic apheresis in autoimmune and rheumatic diseases

✍ Anna P. Koo 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB 👁 2 views

Therapeutic apheresis in hematological a

Therapeutic apheresis in hematological and oncological diseases

✍ Kathleen M. Grima 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB 👁 2 views

Therapeutic apheresis in renal and metab

Therapeutic apheresis in renal and metabolic diseases

✍ Jeffrey L. Winters; Alvaro A. Pineda; Bruce C. McLeod; Kathleen M. Grima 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB 👁 2 views

Phytanic acid storage disease (Refsum's

Phytanic acid storage disease (Refsum's disease): Clinical characteristics, pathophysiology and the role of therapeutic apheresis in its management

✍ Robert Weinstein 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 26 KB 👁 2 views

Phytanic acid storage disease (known also as Refsum's Disease) is caused by inherited defects in the metabolic pathway for phytanic acid, a dietary branched-chain fatty acid. Poorly metabolized phytanic acid accumulates in fatty tissues, including myelin sheaths, and in organs including the liver an

Status of therapeutic apheresis in Europ

Status of therapeutic apheresis in Europe

✍ Hans J. Gurland 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 336 KB 👁 1 views

The development and future trend of therapeutic apheresis in Europe was analyzed. Demographic data on its distribution were collected with the help of the marketing departments of four commercial companies. The differences in application in European countries were examined and compared with North Am